Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia
PLOS ONE · 03.06.2024 · 19 (6) · e0304576
DOI: 10.1371/journal.pone.0304576 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.06.2024. Verfasst von Anna V Jones und 8 weiteren Autor:innen. Beteiligte Einrichtung: Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America. Hauptthemen laut MEDLINE: Syphilis, Penicillin G Benzathine, Pregnancy Complications, Infectious, Prenatal Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The prevalence of syphilis in Zambia remains high and is a critical public health concern. The Zambian Ministry of Health recommends universal screening and same-day treatment for syphilis in pregnancy, yet the syphilis screening rate is low, and treatment is poorly documented. The goal of this study was to document syphilis treatment rates and associated factors among pregnant women in care in Zambia.
Methods
This retrospective cohort study included pregnant women diagnosed with syphilis according to rapid plasma reagin (RPR) screening during routine antenatal care (ANC) in Lusaka, Zambia in 2018–2019. The main outcome of interest was lack of documented BPG treatment during pregnancy. Additional information about pregnancy and neonatal outcomes, partner referral for therapy, and facility level stockout data were included. Patient characteristics were compared by treatment status using Pearson Chi-Square Test and logistic regression models were created to estimate the association between individual level-factors, facility type, and lack of BPG treatment. A Cochran-Mantel-Haenszel test was used to evaluate facility-level data with significance set at p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
- Department of Pediatrics, University of Alabama at Birmingham, Children's of Alabama Hospital, Birmingham, Alabama, United States of America.
- Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
- Center for Women's Reproductive Health, University of Alabama at Birmingham, University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States of America.
- Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States of America.
ORCID-Profile: Anna V Jones, Albert Manasyan
Zitieren
APA
Jones, A. V., Manasyan, A., Xue, Y., Kapesa, H., Mwendafilumba, K., Nalwamba, L., Mzumara, M., Mubiana-Mbewe, M., & Dionne, J. A. (2024). Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia. PLOS ONE, 19(6), e0304576. https://doi.org/10.1371/journal.pone.0304576
Vancouver
Jones AV, Manasyan A, Xue Y, Kapesa H, Mwendafilumba K, Nalwamba L, et al. Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia. PLOS ONE. 2024;19(6):e0304576. doi:10.1371/journal.pone.0304576
BibTeX
@article{Jones2024,
author = {Jones, Anna V and Manasyan, Albert and Xue, Yumo and Kapesa, Herbert and Mwendafilumba, Kate and Nalwamba, Leukanji and Mzumara, Maureen and Mubiana-Mbewe, Mwangelwa and Dionne, Jodie A},
title = {Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {6},
pages = {e0304576},
doi = {10.1371/journal.pone.0304576}
}
EUVIMED